This compound, a factor Xa inhibitor, was discovered and advanced into the clinic by Bristol-Myers Squibb (BMS).

FORBES: Why Is Pharma Out-Licensing Its Compounds?

Pfizer had their own factor Xa inhibitor in development , but it was at least a year behind the BMS program.

FORBES: Why Is Pharma Out-Licensing Its Compounds?